Kara Ahmet, Elden Halil, Okur Engin, Yilmaz Mahmut Sinan, Mutlu Fuldem, Guven Mehmet, Demir Deniz
Department of Otorhinolaryngology, Sakarya University Faculty of Medicine, Sakarya, Turkey.
Department of Radiology, Sakarya University Faculty of Medicine, Sakarya, Turkey.
Acta Otolaryngol. 2021 Sep;141(9):857-859. doi: 10.1080/00016489.2021.1970803. Epub 2021 Sep 5.
Due to many different reasons such as possible coronavirus colonization in tonsillar tissue, decreased enzymatic antiviral activity, decreased cytokine activity from palatine tonsil tissue and reduced humoral and cellular immune response, tonsillectomy may alter the incidence of Covid-19.
AIMS/OBJECTIVES: To reveal the frequency of Covid-19 in patients who underwent tonsillectomy and to analyze the effect of tonsillectomy on the severity of the disease.
Patients aged between 15 and 65 and had a history of tonsillectomy were compared with control group in terms of incidence and severity of Covid-19 disease.
A 4% Covid rRT-PCR test positivity rate was detected in patients with tonsillectomy whereas; it was 6.8% in the control group with a statistically significant difference. However, in terms of disease severity there was no difference between the two groups.
It has been proven that tonsillectomy surgery does not pose an additional risk in terms of COVID 19 disease severity. The positive effect of tonsillectomy in terms of disease frequency has been even demonstrated for the first time in the literature.
由于多种不同原因，如扁桃体组织可能存在冠状病毒定植、酶促抗病毒活性降低、腭扁桃体组织细胞因子活性降低以及体液和细胞免疫反应减弱，扁桃体切除术可能会改变新冠病毒疾病（Covid-19）的发病率。
揭示接受扁桃体切除术患者中新冠病毒疾病（Covid-19）的发生率，并分析扁桃体切除术对该疾病严重程度的影响。
将年龄在15至65岁之间且有扁桃体切除术史的患者与对照组在新冠病毒疾病（Covid-19）的发病率和严重程度方面进行比较。
扁桃体切除术患者的新冠病毒逆转录聚合酶链反应（rRT-PCR）检测阳性率为4%，而对照组为6.8%，差异具有统计学意义。然而，在疾病严重程度方面，两组之间没有差异。
已证实扁桃体切除术在新冠病毒疾病（COVID-19）严重程度方面不会带来额外风险。扁桃体切除术在疾病发生率方面的积极作用在文献中首次得到证实。
